HealthExec March 4, 2025
Chad Van Alstin

A private equity firm is set to close a $10 billion Walgreens buyout, people familiar with the deal told the Wall Street Journal.

According to the report, the deal could be finalized before the end of the week, with terms involving Sycamore Partners taking ownership of the struggling pharmacy chain. Sycamore Partners is a New York-based firm whose portfolio includes Staples, Belk and Hot Topic.

Talks surrounding the pending buyout were first revealed in December 2024.

The details being ironed out involve Sycamore Partners paying between $11.30 and $11.40 per share for Walgreens, which...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
FTC lawsuit against PBMs can move forward after Ferguson rejoins case
What’s going on with Walgreens?
RFK Jr. May Want To Ban Prescription Drug Ads, But Can He?
M&A recap: Big pharma starts the year mostly avoiding billion-dollar deals
FTC pauses PBM litigation in win for Caremark, Express Scripts, Optum Rx

Share This Article